Admission and listing of rights to series T ordinary bearer shares.

Current Report No. 44/2024 

Date of preparation: December 18, 2024. 

Subject: Admission and listing of rights to series T ordinary bearer shares. 

Legal basis: Article 56 (1) (2) of the Act on Offering - current information. 

The Management Board of Captor Therapeutics S.A., based in Wrocław, Poland (“Company”), has received information about the decision of the Management Board of the Warsaw Stock Exchange S.A. (“WSE”) resolution No. 1648/2024 of December 18, 2024 on the admission and introduction to exchange trading on the WSE Main Market of 822,467 rights to Series T ordinary bearer shares of the Company, provided that the National Securities Depository S.A., registers these rights to shares and designates them with the code “PLCPTRT00063” no later than December 23, 2024. 

The resolution comes into force on the date of adoption. 

Detailed legal basis: § 17 (1) (2) of the Regulation of the Minister of Finance dated March 29, 2018 on current and periodic information provided by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state member state.